Trial Profile
Angiotensin Receptors and Age Related Mitochondrial Decline in HIV Patients
Status:
Discontinued
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Valsartan (Primary)
- Indications Mitochondrial disorders; Muscular atrophy
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms RAS-HIV
- 24 Jan 2017 Status changed from recruiting to discontinued due to change in study design and inability to recruit participants
- 19 Nov 2015 New trial record